rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-8-3
|
pubmed:abstractText |
To assess the efficacy of a single, oral dose of etodolac (300 mg), a nonsteroidal antiinflammatory drug, on gait and pain in patients with unilateral hip osteoarthritis (hOA).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1063-4584
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
230-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10806051-Adult,
pubmed-meshheading:10806051-Aged,
pubmed-meshheading:10806051-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:10806051-Cross-Over Studies,
pubmed-meshheading:10806051-Double-Blind Method,
pubmed-meshheading:10806051-Etodolac,
pubmed-meshheading:10806051-Female,
pubmed-meshheading:10806051-Gait,
pubmed-meshheading:10806051-Humans,
pubmed-meshheading:10806051-Male,
pubmed-meshheading:10806051-Middle Aged,
pubmed-meshheading:10806051-Osteoarthritis, Hip,
pubmed-meshheading:10806051-Pain Measurement,
pubmed-meshheading:10806051-Range of Motion, Articular,
pubmed-meshheading:10806051-Therapeutic Equivalency,
pubmed-meshheading:10806051-Time Factors,
pubmed-meshheading:10806051-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur.
|
pubmed:affiliation |
Department of Rheumatology, Centre Hospitalo-Universitaire de Rouen, France. Othmane.Mejjad@chu-rouen.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|